BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 660508)

  • 1. Cloprednol bioavailability in humans.
    Mroszczak EJ; Runkel R; Strand LJ; Tomlinson RV; Fratis A; Segre E
    J Pharm Sci; 1978 Jul; 67(7):920-3. PubMed ID: 660508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cloprednol use in chronic asthma.
    Gavani UD; Hyde JS; Khurana S; Manaligod LM
    JAMA; 1979 Dec; 242(24):2679-82. PubMed ID: 501863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of cloprednol.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H; Krieg M; Weisser H; Möllmann AC
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):1-5. PubMed ID: 8688990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cloprednol in healthy volunteers.
    Legler UF
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):173-5. PubMed ID: 3403094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloprednol therapy in steroid-dependent asthma.
    Shapiro GG; Tattoni DS; Kelley VC; Pierson WE; Dorsett CS; Bierman CW
    Pediatrics; 1979 May; 63(5):747-53. PubMed ID: 440895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of cloprednol-a new systemic corticosteroid.
    Ortega E; Rodriguez C; Strand LJ; Bessler S; Segre E
    J Clin Pharmacol; 1976; 16(2-3):122-8. PubMed ID: 1254734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal axis function.
    Ortega E; Rodriguez C; Strand LJ; Segre E
    J Int Med Res; 1976; 4(5):326-37. PubMed ID: 1028634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative and absolute bioavailability of cibenzoline capsules and tablets in healthy subjects.
    Massarella J; Silvestri T; Lin A
    J Pharm Sci; 1986 Sep; 75(9):894-6. PubMed ID: 3783460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of ergoloid mesylates liquid capsule.
    Schran HF
    Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.